Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Oral Nano-emulsified Cannabidiol in Healthy Volunteers
TCTR20231114007Phase 1Unknown
- Sponsor
- Chakrabongse Aiewtrakoon
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of cannabidiol, sponsored by Chakrabongse Aiewtrakoon. Primary endpoints: Pharmacokinetic parameters of CBD-NE and Safety and tolerability of CBD-NE. Status: unknown.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on TCTR20231114007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231114007.